nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
A Canadian Perspective
|
Otten, Nicolaas |
|
1998 |
1 |
4 |
p. 218-223 6 p. |
artikel |
2 |
A Managed Care Perspective
|
Bonnette, James |
|
1998 |
1 |
4 |
p. 231-232 2 p. |
artikel |
3 |
A Pharmacy Benefit Manager Perspective
|
Teagarden, J. Russell |
|
1998 |
1 |
4 |
p. 233-236 4 p. |
artikel |
4 |
A UK Perspective
|
Davey, Peter |
|
1998 |
1 |
4 |
p. 224-227 4 p. |
artikel |
5 |
A US Military Perspective
|
Remund, Daniel D. |
|
1998 |
1 |
4 |
p. 228-230 3 p. |
artikel |
6 |
Commentary on Langley and McKenney Papers
|
Ashraf, Talat |
|
1998 |
1 |
4 |
p. 216-217 2 p. |
artikel |
7 |
Criteria for the Economic Evaluation of Lipid Studies in Health Systems
|
Langley, Paul C. |
|
1998 |
1 |
4 |
p. 208-211 4 p. |
artikel |
8 |
Employer and Consumer Perspectives
|
McGhan, William F. |
|
1998 |
1 |
4 |
p. 237-242 6 p. |
artikel |
9 |
From Research into Practice: How Should Healthcare Organizations/Governments Decide about Lipid Therapy and Who Will Pay? Reactor Panel and Open Forum
|
Langley, Paul C. |
|
1998 |
1 |
4 |
p. 243-250 8 p. |
artikel |
10 |
Patient Education and Compliance: How to Make It Cost-Effective
|
McKenney, James M. |
|
1998 |
1 |
4 |
p. 212-215 4 p. |
artikel |
11 |
Prevalence-Based Economic Evaluation
|
Mauskopf, Josephine |
|
1998 |
1 |
4 |
p. 251-259 9 p. |
artikel |
12 |
What Is Happening in the Real World in Lipid Therapy and Is It Appropriate? The Need for a Paradigm Shift
|
Smith Jr., Sidney C. |
|
1998 |
1 |
4 |
p. 204-207 4 p. |
artikel |
13 |
Willingness to Pay versus Willingness to Buy: What Defines Value in Healthcare?
|
Berger, Marc |
|
1998 |
1 |
4 |
p. 201-203 3 p. |
artikel |